Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$36,940,047
+$5,321,114 QoQ
Shares Held
30,798
-10.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.17%
of 13F equity value
Holder Rank
#631
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 2%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First National Trust Co holds $128,309,128 across 8 Drug Manufacturers - General names. LLY ranks #1 (28.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
30,798 | $36,940,047 | |
| 2 | JNJ |
Johnson & Johnson
|
125,659 | $31,913,616 | |
| 3 | MRK |
Merck & Co., Inc.
|
179,140 | $23,019,489 | |
| 4 | ABBV |
AbbVie Inc.
|
74,068 | $18,638,470 | |
| 5 | AMGN |
Amgen Inc
|
42,011 | $15,213,022 | |
| 6 | PFE |
Pfizer Inc
|
52,136 | $1,255,434 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,277 | $1,110,740 | |
| 8 | NVS |
Novartis AG
|
1,393 | $218,310 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,940,047 | 30,798 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $31,618,933 | 34,377 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $34,946,446 | 32,518 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $24,976,805 | 32,735 | Shares | Other | 2025-11-06 | |
| 2025-06-30 | $25,403,323 | 32,588 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $27,594,478 | 33,411 | Shares | Other | 2025-05-08 | |
| 2024-12-31 | $26,275,020 | 34,035 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $27,410,097 | 30,939 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $28,197,154 | 31,144 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $23,033,839 | 29,608 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $14,620,216 | 25,081 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $13,649,009 | 25,411 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $12,022,302 | 25,635 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $8,958,797 | 26,087 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $9,679,393 | 26,458 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $8,721,718 | 26,973 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $8,869,635 | 27,356 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $8,247,168 | 28,799 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $8,150,698 | 29,508 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $7,083,067 | 30,656 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $7,107,545 | 30,967 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $6,011,493 | 32,178 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $5,649,216 | 33,459 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $5,212,227 | 35,213 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $5,893,404 | 35,896 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $5,076,041 | 36,592 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||